Leveraging AI & mHealth Data to Improve Diagnostics
Medxtractor Corp. (CSE: MXT) (OTC: MXXTF) developed SHAMAN to aggregate mHealth data and improve the diagnosis of mental health conditions, working hand-in-hand with psychedelics to improve patient outcomes.
Download the investor presentation and receives updates:
Mental Health Challenges
Misdiagnosis rates range from 65.9% for major depressive disorder to 97.8% for social anxiety disorder.
Medical errors are the third leading cause of death in the U.S. and medication errors harm 1.5M people.
Lack of Coherent, Valid Data
Many existing drugs have questionable efficacy and psychedelics have an opportunity to revolutionize the market.
SHAMAN was built to make sense of massive amounts of data and provide more accurate diagnoses.
How SHAMAN Helps
SHAMAN aggregates data from brain wave scans to the growing number of wearable devices.
SHAMAN standardizes the data, determines its relevance and creates a central knowledgebase.
SHAMAN makes more accurate diagnostic opinions using its massive data stores and AI algorithms.
SHAMAN's core technologies can be applied to almost any industry with massive data sets.